Panel discussion on mantle cell lymphoma
Constantine Tam et al.
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Minimal residual disease (MRD) monitoring for multiple myeloma is here to stay
New drug targets for AML
Moving towards personalized therapy for AML